AI is powerful, but the drug and the patient come first. This boardroom explores how teams can leverage AI safely, integrate it into workflows, and maintain human control with strong processes.
Shift from “random prompting” to building Structured Supply Chain AI Workflows that save hours while keeping human oversight and data security intact
Outcome: Each table will collaborate to create practical strategies, and governance approaches that balance AI capabilities with human oversight, ensuring AI enhances decisions rather than replacing critical thinking.
AI with a Human Touch: Practical Strategies for Smart, Safe Adoption
- How to align CDMO partnerships with phase-specific needs while staying agile
- How to collaborate across CDMOs and ensure smooth tech transitions, especially for biologics therapies
- How to build transparent CDMO partnerships from Day 1 to overcome challenges and save costs
Moderator: Amanda Murphy, Head of Digital Product Management, GlobalData
- Panelist 1: Aimee Hogue, Director Supply Chain, Sutro Biopharma
- Panelist 2: Amber Bill, Associate Director, Sangamo Therapeutics
Panelist 3: Burkard Kolb, Former Executive Director, CMC Operations, 89bio (Genentech)